This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

NeoStem To Present At Multiple November Conferences

NEW YORK, Oct. 31, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company and its subsidiary, Progenitor Cell Therapy ("PCT"), will present at multiple upcoming conferences in November.

BIO-Europe 2013-19 th Annual International Partnering Conference

  • Date and Time: Monday, November 4, 2013, 2:45 PM CEST
  • Venue: Messe Wien Exhibition and Congress Center, Vienna, Austria
  • Session: "What is the role of large pharma in developing advanced therapy medicinal products—are they essential or not?"
  • Moderator: Robert A. Preti, Ph.D., Chief Scientific Officer, NeoStem, and President, PCT

Landmark Venture Forum – Investing for Cures 2013

  • Date and Time: Wednesday, November 6, 2013, 2:00 PM EST
  • Venue: Union League Club, New York, New York
  • Session: Company Presentation
  • Speaker: Robin L. Smith, MD, MBA, Chairman and CEO, NeoStem

American Heart Association Annual Scientific Sessions 2013

  • Venue: Dallas Convention Center, Dallas, Texas
  • Date and Time: Monday, November 18, 2013, 9:00 AM CST
  • Session 1: "Clinical Science Special Reports"
  • Panelist: Douglas W. Losordo, MD, Chief Medical Officer, NeoStem
  • Date and Time: Tuesday, November 19, 2013, 9:00 AM CST
  • Session 2: "George E. Brown Memorial Lecture and Adult Stem Cells: Cardiac Homeostasis and Repair"
  • Moderator: Douglas W. Losordo, MD, Chief Medical Officer, NeoStem

11 th Annual Commercial Translation of Regenerative Medicine 2013

  • Date and Time: Tuesday, November 26, 4:20 PM BST
  • Venue: Charing Cross Hotel, London, United Kingdom
  • Session: "Case Study - Capturing and Preparing for Licensing and Acquisition"
  • Speaker: Robin L. Smith, MD, MBA, Chairman and CEO, NeoStem

London Regenerative Medicine Network

  • Date and Time: Tuesday, November 26, 6:35 PM BST
  • Venue: University College London, Bloomsbury campus, London, United Kingdom
  • Session: Company Presentation
  • Speaker: Robin L. Smith, MD, MBA, Chairman and CEO, NeoStem

About NeoStem, Inc.

NeoStem, Inc. is a leader in the emerging cellular therapy industry. Our business model includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization providing services to others in the regenerative medicine industry. The combination of a therapeutic development business and revenue-generating service provider business provides the Company with capabilities for cost effective in-house product development and immediate revenue and cash flow generation.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,912.11 -70.48 -0.42%
S&P 500 1,969.95 -8.96 -0.45%
NASDAQ 4,442.6980 -2.2110 -0.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs